Investing.com - Oxford BioMedica reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Oxford BioMedica announced earnings per share of £-0.27 on revenue of £64.03M. Analysts polled by Investing.com anticipated EPS of £-11.90 on revenue of £56.80M.
Oxford BioMedica shares are down 64.27% from the beginning of the year and are trading at £439.50 , down-from-52-week-high.
Oxford BioMedica follows other major Healthcare sector earnings this month
Oxford BioMedica's report follows an earnings missed by Spire Healthcare on Thursday, September 8, 2022, who reported EPS of £-0 on revenue of £596.2M, compared to forecasts EPS of £2.80 on revenue of £590.80M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar